Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<jats:sec><jats:title>Objectives</jats:title><jats:p>To explore UK clinicians’ beliefs and behaviours around recommending e-cigarettes as a smoking cessation aid for patients with cancer.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Cross-sectional online survey.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>England, Wales, Scotland and Northern Ireland.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>Clinicians involved in the care of patients with cancer.</jats:p></jats:sec><jats:sec><jats:title>Primary and secondary outcomes</jats:title><jats:p>Behavioural Change Wheel capability, opportunity and motivation to perform a behaviour, knowledge, beliefs, current practice around e-cigarettes and other smoking cessation practices.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Clinicians (n=506) completed an online survey to assess beliefs and behaviours around e-cigarettes and other smoking cessation practices for patients with cancer. Behavioural factors associated with recommending e-cigarettes in practice were assessed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>29% of clinicians would not recommend e-cigarettes to patients with cancer who continue to smoke. Factors associated with recommendation include smoking cessation knowledge (OR 1.56, 95% CI 1.01 to 2.44) and e-cigarette knowledge (OR 1.64, 95% CI 1.06 to 2.55), engagement with patients regarding smoking cessation (OR 2.12, 95% CI 1.12 to 4.03), belief in the effectiveness of e-cigarettes (OR 2.36 95% CI 1.61 to 3.47) and belief in sufficient evidence on e-cigarettes (OR 2.08 95% CI 1.10 to 4.00) and how comfortable they felt discussing e-cigarettes with patients (OR 1.57 95% CI 1.04 to 2.36).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Many clinicians providing cancer care to patients who smoke do not recommend e-cigarettes as a smoking cessation aid and were unaware of national guidance supporting recommendation of e-cigarettes as a smoking cessation aid.</jats:p></jats:sec>

Original publication

DOI

10.1136/bmjopen-2020-037637

Type

Journal article

Journal

BMJ Open

Publisher

BMJ

Publication Date

19/11/2020

Volume

10

Pages

e037637 - e037637